Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT00454142Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2007
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in nasopharyngeal carcinoma (NPC), sponsored by National Cancer Institute. Started Aug 2007; status: completed.
02
Drugs
pazopanib
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00454142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454142.